Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death

被引:37
作者
Battaglia, G
Bruno, V
Ngomba, RT
Di Grezia, R
Copani, A
Nicoletti, F [1 ]
机构
[1] INM Neuromed, Pozzilli, Italy
[2] Univ Catania, Sch Pharm, Inst Pharmacol, I-95125 Catania, Italy
关键词
aminopyrrolidine-2R; 4R-dicarboxylated; mGlu(2); receptor; mGlu(3); neuroprotection;
D O I
10.1016/S0014-2999(98)00551-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aminopyrrolidine-2 R,4 R-dicarboxylated (2 R,4 R-APDC) has recently been introduced as a potent and highly selective agonist of metabotropic glutamate (mGlu) receptor subtypes mGlu(2) and -(3). In murine cortical cultures containing both neurons and astrocytes, 2R,4R-APDC attenuated the delayed neuronal degeneration induced by a 10-min pulse of N-methyl-D-aspartate (NMDA). 2R,4R-APDC was maximally neuroprotective in a range of concentrations (0.1-1 mu M) comparable to that reported for the activation of mGlu(2) or -(3) receptors in heterologous expression systems. The action of 2R,4R-APDC was sensitive to the mGlu(2/3) receptor antagonists, (2S)-alpha-ethylglutamate and (2S,1S',2S',3R')-2-(2'-carboxy-3'-phenylcyclopropyl)glycine. These results indicate that activation of mGlu(2) and/or -(3) receptors is sufficient per se to protect neurons against excitotoxic degeneration, and encourage the search for potent, selective and systemically active mGlu(2/3) receptor agonists as neuroprotective drugs. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 27 条
[1]  
AMBROSINI A, 1995, MOL PHARMACOL, V47, P1057
[2]   In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats [J].
Battaglia, G ;
Monn, JA ;
Schoepp, DD .
NEUROSCIENCE LETTERS, 1997, 229 (03) :161-164
[3]   PHENYLGLYCINE DERIVATIVES DISCRIMINATE BETWEEN MGLUR1-MEDIATED AND MGLUR5-MEDIATED RESPONSES [J].
BRABET, I ;
MARY, S ;
BOCKAERT, J ;
PIN, JP .
NEUROPHARMACOLOGY, 1995, 34 (08) :895-903
[4]   ACTIVATION OF CLASS-II OR CLASS-III METABOTROPIC GLUTAMATE RECEPTORS PROTECTS CULTURED CORTICAL-NEURONS AGAINST EXCITOTOXIC DEGENERATION [J].
BRUNO, V ;
BATTAGLIA, G ;
COPANI, A ;
GIFFARD, RG ;
RACITI, G ;
RAFFAELE, R ;
SHINOZAKI, H ;
NICOLETTI, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1995, 7 (09) :1906-1913
[5]   PROTECTIVE EFFECT OF THE METABOTROPIC GLUTAMATE-RECEPTOR AGONIST, DCG-IV, AGAINST EXCITOTOXIC NEURONAL DEATH [J].
BRUNO, V ;
COPANI, A ;
BATTAGLIA, G ;
RAFFAELE, R ;
SHINOZAKI, H ;
NICOLETTI, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 256 (01) :109-112
[6]  
Bruno V, 1997, J NEUROSCI, V17, P1891
[7]  
BRUNO V, 1998, IN PRESS NEUROSCIENC
[8]   DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons [J].
Buisson, A ;
Yu, SP ;
Choi, DW .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (01) :138-143
[9]   THE INHIBITORY MGLUR AGONIST, S-4-CARBOXY-3-HYDROXY-PHENYLGLYCINE SELECTIVELY ATTENUATES NMDA NEUROTOXICITY AND OXYGEN GLUCOSE DEPRIVATION-INDUCED NEURONAL DEATH [J].
BUISSON, A ;
CHOI, DW .
NEUROPHARMACOLOGY, 1995, 34 (08) :1081-1087
[10]  
BUISSON A, 1994, SOC NEUR ABSTR, V20